Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jeong Won Kang

Phase I and Pharmacokinetic Study of the Vascular‐disrupting Agent CKD‐516 (NOV120401) in Patients With Refractory Solid Tumors

Pharmacology Research and Perspectives

English

Related publications

Phase I Study of Single-Agent Ribociclib in Japanese Patients With Advanced Solid Tumors

English

Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin, and Daily Capecitabine in Patients With Advanced Solid Tumors

Clinical Cancer Research

Cancer Research

Oncology

2005

English

Phase I Trial and Pharmacokinetic Study of Ixabepilone Administered Daily for 5 Days in Children and Adolescents With Refractory Solid Tumors

Journal of Clinical Oncology

English

Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

Clinical Cancer Research

Cancer Research

Oncology

2006

English

Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors

Investigational New Drugs

Oncology

Pharmacology

2010

English

Phase I and Pharmacokinetic Study of Cetuximab and Irinotecan in Children With Refractory Solid Tumors: A Study of the Pediatric Oncology Experimental Therapeutic Investigators' Consortium

Journal of Clinical Oncology

English

Phase I and Pharmacokinetic Study of 7-Hydroxystaurosporine and Carboplatin in Advanced Solid Tumors

Clinical Cancer Research

Cancer Research

Oncology

2007

English

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients With Advanced Solid Tumors

Clinical Cancer Research

Cancer Research

Oncology

2011

English

A Phase I Trial of UCN-01 and Prednisone in Patients With Refractory Solid Tumors and Lymphomas

Cancer Chemotherapy and Pharmacology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jeong Won Kang

Phase I and Pharmacokinetic Study of the Vascular‐disrupting Agent CKD‐516 (NOV120401) in Patients With Refractory Solid Tumors

Related publications

Phase I Study of Single-Agent Ribociclib in Japanese Patients With Advanced Solid Tumors

Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin, and Daily Capecitabine in Patients With Advanced Solid Tumors

Phase I Trial and Pharmacokinetic Study of Ixabepilone Administered Daily for 5 Days in Children and Adolescents With Refractory Solid Tumors

Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors

Phase I and Pharmacokinetic Study of Cetuximab and Irinotecan in Children With Refractory Solid Tumors: A Study of the Pediatric Oncology Experimental Therapeutic Investigators' Consortium

Phase I and Pharmacokinetic Study of 7-Hydroxystaurosporine and Carboplatin in Advanced Solid Tumors

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients With Advanced Solid Tumors

A Phase I Trial of UCN-01 and Prednisone in Patients With Refractory Solid Tumors and Lymphomas